unknown
Stage
About
Viramal is a UK-based specialist pharmaceutical company developing prescription and non-prescription therapies for women's sexual and reproductive health. Its pipeline focuses on conditions such as endometriosis, chronic pelvic pain, menopause and the vaginal microbiome, using targeted delivery methods including transdermal, buccal and vaginal applications.
Explore Viramal's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.